Head-to-head · free

Morgan Stanley vs REX NVDA Growth & Income ETF

MS vs NVII — return on capital, cash generation, margins and balance sheet side by side.

MS

0 / 0

measures where MS leads

NVII

0 / 0

measures where NVII leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureMS · FY2025NVII
Revenue——
Net income$16.9B—
Revenue growth (yearly, multi-year)——
Free cash flow——
Free cash flow margin——
Net cash / (debt)——
ROIC——
Return on equity16.5%—
Gross margin——
Operating margin——
Net debt / EBITDA——

Figures are as reported by each company; latest fiscal year shown.

Where Morgan Stanley's cash went (FY2025)

Capital spending
—
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full MS profile →

Where REX NVDA Growth & Income ETF's cash went

Not reported yet.

Full NVII profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons